FDA product code · Immunology

Cancer Monitoring Test System, Soluble Mesothelin-Related Peptides, Mesothelioma

Name: FDA decisions, review times, recalls and adverse event reports for product code NVA
Creator: 510(k) Report

NVAClass II21 CFR 866.6010510(k) required0 decisions0 recalls

0 FDA decisions. No recall names this code.

MONITORING CANCER PATIENTS AFTER THERAPY FOR DISEASE PROGRESSION IN CONJUNCTION WITH OTHER DIAGNOSTIC MODALITIES.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, immunology panel

Twenty years of NVA at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FIG. 1 — NVA by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in NVA? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 866.6010.

OXP Dna-Probe Kit, Human Chromosome X And Y, Bmt…MUT Kit, Test For Nuclear Matrix (Numa) Protein…MSW System, Test, Thyroglobulin MOI System, Test, Immunological, Antigen, Tumor DHX System, Test, Carcinoembryonic Antigen NIG System, Test, Carbohydrate Antigen (Ca19-9)…OIU Test, Epithelial Ovarian Tumor Associated…LTJ Prostate-Specific Antigen (Psa) For Management…QXS Chromogranin A LOQ Device, General Purpose, Hematology OVK Cytokeratin Fragments 21-1 Eia Kit MMW System, Test, Tumor Marker, Monitoring, Bladder